Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Marsh, J. E
Right arrow Articles by Andrews, P. A
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Management of the diabetic patient approaching end-stage renal failure

James E Marsh

Renal Unit, Guy's Hospital, London, UK

Peter A Andrews

SW Thames Renal & Transplantation Unit, St Helier Hospital, Carshalton, Surrey, SM5 1AA, UK, pandrews{at}sthelier.sghms.ac.uk

References

  • Parving HH, Andersen AR, Smidt UM et al. Diabetic nephropathy and arterial hypertension. Diabetologia 1983;24:10-12.[Web of Science][Medline] [Order article via Infotrieve]
  • Kussman MJ, Goldstein H., Gleason RE The clinical course of diabetic nephropathy. JAMA 1976;236:1861-3.[Abstract/Free Full Text]
  • Wang PH, Lau J., Chalmers TC Meta-analysis of effects of intensive blood-glucose control on late complications of type I diabetes. Lancet 1993;341:1306-09.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-20.[Abstract/Free Full Text]
  • The ACE Inhibitors in Diabetic Nephropathy Trialist Group. Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data. Ann Intern Med 2001;134: 370-9.[Abstract/Free Full Text]
  • Brenner BM, Cooper ME, de Zeeuw D. et al. RENAAL study I. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.[Abstract/Free Full Text]
  • Parving HH, Lehnert H., Brochner-Mortensen J., Gomis R., Andersen S., Arne P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-8.[Abstract/Free Full Text]
  • Lewis EJ, Hunsicker LG, Clarke WR et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001;345:851-60.[Abstract/Free Full Text]
  • Hovind P., Rossing P., Tarnow L., Smidt UM, Parving HH Progression of diabetic nephropathy. Kidney Int 2001;59:702-09.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hansson L., Zanchetti A., Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Parving HH, Hovind P., Rossing K., Andersen S. Evolving strategies for renoprotection: diabetic nephropathy. Curr Opin Nephrol Hyperten 2001;10:515-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Clark Jr CM, Lee DA Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 1995;332:1210-17.[Free Full Text]
  • Manske CL, Thomas W., Wang Y., Wilson RF Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 1993;44:617-21.[Web of Science][Medline] [Order article via Infotrieve]
  • Christians U., Jacobsen W., Floren LC Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Therap 1998;80:1-34.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yusuf S., Sleight P., Pogue J. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]
  • Manske CL, Wang Y., Rector T. et al. Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 1992;340:998-1002.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ishimura E., Nishizawa Y., Okuno S. et al. Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure. J Nephrol 1998;11:83-6.[Web of Science][Medline] [Order article via Infotrieve]
  • Churchill DN, Muirhead N., Goldstein M. et al. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients. Clin Nephrol 1995;43:184-8.[Web of Science][Medline] [Order article via Infotrieve]
  • Locatelli F., Conte F., Marcelli D. The impact of haematocrit levels and erythropoietin treatment on overall and cardiovascular mortality and morbidity - the experience of the Lombardy Dialysis Registry. Nephrol Dial Transplant 1998;13:1642-4.[Free Full Text]
  • Working Party for European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure. European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 1999;14S5:1-50.
  • Goldsmith DJ, Covic A., Sambrook PA, Ackrill P. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 1997;77:37-43.[Web of Science][Medline] [Order article via Infotrieve]
  • Lazarus JM, Lowrie EG, Hampers CL, Merrill JP Cardiovascular disease in uremic patients on hemodialysis. Kidney Int 1975;S2:167-75.
  • Amann K., Gross ML, London GM, Ritz E. Hyperphosphataemia - a silent killer of patients with renal failure? Nephrol Dial Transplant 1999;14:2085-7.[Free Full Text]
  • Andrews PA, Warr KJ, JA Hicks, Cameron JS Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients. Nephrol Dial Transplant 1996;11: 1104-08.[Abstract/Free Full Text]
  • Aman LC, Levin NW, Smith DW Hemodialysis access site morbidity. Proc Clinical Dialysis & Transplant Forum 1980; 10:277-84.
  • Ojo O., Meier-Kriesche HU, Hanson JA et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001;71:82-90.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Annual Report of the U.S. Scientific Registry for Transplant Recipients and the Organ Procurement and Transplantation Network: Transplant Data: 1989-1998; US Department of Health and Human Services, Health Resources and Services Administration, Office of Special Programs, Division of Transplantation, Rockville, MD. Richmond, VA: UNOS
  • Pirsch JD, Andrews C., Hricik DE et al. Pancreas transplantation for diabetes mellitus. Am J Kidney Dis 1996;27:444-50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Solders G., Tyden G., Persson A., Groth CG Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 years after combined pancreatic and renal transplantation. Diabetes 1992;41:946-51.[Abstract]
  • Nakache R., Tyden G., Groth CG Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes 1989;38S1:40-42.
  • Bohman SO, Tyden G., Wilczek H. et al. Prevention of kidney graft diabetic nephropathy by pancreas transplantation in man. Diabetes 1985;34:306-08.[Abstract]
  • US Renal Data System. ADR: Simultaneous kidney-pancreas transplantation versus kidney transplantation alone: patient survival, kidney graft survival, and post-transplant hospitalization. Am J Kidney Dis 1992;20 S2:61-7.[Medline] [Order article via Infotrieve]
  • Wilczek H., Gunnarsson R., Lundgren G., Ost L. Improved results of renal transplantation in diabetic nephropathy. Transplant Proc 1984;16:623-7.[Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 2, 121-126 (2002)
DOI: 10.1177/14746514020020021001


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Marsh, J. E
Right arrow Articles by Andrews, P. A
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?